An important component of tissue engineering (TE) is the supporting matrix upon which cells and tissues grow, also known as the scaffold. Scaffolds must easily integrate with host tissue and provide an excellent environment for cell growth and differentiation. Most scaffold materials are naturally derived from mammalian tissues. The amniotic membrane (AM) is considered an important potential source for scaffolding material. The AM represents the innermost layer of the placenta and is composed of a single epithelial layer, a thick basement membrane and an avascular stroma. The special structure and biological viability of the AM allows it to be an ideal candidate for creating scaffolds used in TE. Epithelial cells derived from the AM have the advantages of stem cells, yet are a more suitable source of cells for TE than stem cells. The extracellular matrix components of the basement membrane of the AM create an almost native scaffold for cell seeding in TE. In addition, the AM has other biological properties important for TE, including anti-inflammatory, anti-microbial, anti-fibrosis, anti-scarring, as well as reasonable mechanical property and low immunogenicity. In this review, the various properties of the AM are discussed in light of their potential use for TE.
Introduction
Tissue engineering (TE) is defined as the development of biological substitutes for the purpose of restoring, maintaining or improving tissue function and requires the application of principles and methods from both engineering and life sciences (Langer and Vacanti, 1993) . Scaffolds are developed to support the host cells during TE, promoting their differentiation and proliferation throughout their formation into a new tissue. Therefore, the design and selection of the biomaterials used for scaffolding is a critical step in TE (Mano et al., 2007) . During TE, cell seeding onto scaffolds is the first step in establishing a three-dimensional culture, and plays a crucial role in determining the progression of the tissue formation (Vunjak-Novakovic et al., 1998) . Successful cell seeding of the scaffold depends on the type and source of the living cells as well as the extracellular matrix (ECM) components of the scaffold.
One of the oldest biomaterials used for scaffolds is the foetal membrane. The foetal membrane was first used for the transplantation of skin in 1910 (Davis, 1910) . Subsequently the foetal membrane was found to be useful in the management of burns; creation of surgical dressings; as well as reconstruction of the oral cavity, bladder, and vagina; tympanoplasty; arthroplasty and so forth (Fernandes et al., 2005) . Specifically, the amniotic membrane (AM) has gained importance because of its ability to reduce scarring and inflammation; enhance wound healing; and serve as a scaffold for cell proliferation and differentiation as a result of its antimicrobial properties. In addition, the ECM of the AM and its components, such as growth factors, suggest that the AM is an excellent candidate to use as a native scaffold for TE. In addition, the AM is a biomaterial that can be easily obtained, processed and transported.
In this review, we will describe the necessary components of tissue engineering, including the potential cells used for differentiation and the properties of a scaffold which would be best suited for the purposes of TE. We then describe the basic structure and properties of the AM that make it an excellent candidate to use as scaffolds in TE.
Anatomy and histology of the amniotic membrane
Amniotic membranes develop from extra-embryonic tissue and consist of a foetal component (the chorionic Use of amniotic membrane for tissue engineering plate) and a maternal component (the deciduas). These two parts are held together by the chorionic villi and connect the cytotrophoblastic shell of the chorionic sac to the decidua basalis. The foetal component, which includes the amniotic and chorionic foetal membranes, separates the foetus from the endometrium. The amniochorionic membrane forms the outer limits of the sac that encloses the foetus, while the innermost layer of the sac is the AM. The AM consists of an epithelial monolayer, a thick basement membrane, and an avascular stroma (Fig. 1) . The AM contains no blood vessels or nerves; instead, the nutrients it requires are supplied directly by diffusion out of the amniotic fluid and/or from the underlining decidua. The innermost layer, nearest to the foetus, is called the amniotic epithelium and consists of a single layer of cells uniformly arranged on the basement membrane. The basement membrane is one of the thickest membranes found in all human tissue. The support provided to the foetus by the basement membrane throughout gestation stands testimony to the structural integrity of this remarkable membrane. The compact layer of stromal matrix adjacent to the basement membrane forms the main fibrous skeleton of the AM. The collagens of the compact layer are secreted by mesenchymal cells situated in the fibroblast layer. Interstitial collagens (types I and III) predominate and form parallel bundles that maintain the mechanical integrity of AM. Collagens type V and VI form filamentous connections between interstitial collagens and the epithelial basement membrane. The intermediate layer (spongy layer or zona spongiosa) of the stromal matrix sits adjacent to the chorionic membrane. Its abundant content of proteoglycans and glycoproteins produces a spongy appearance in histologic preparations, and it contains a nonfibrillar meshwork of mostly type III collagen (Parry and Strauss, 1998) . The spongy layer is loosely connected to the chorionic membrane; hence, the AM is easily separated from the chorion by means of blunt dissection.
The main sources of stem cells currently used for TE
The use of stem cells is an intrinsic part of TE and plays a key role in the creation of implantable tissue. The source of cells utilized in TE can be autologous, meaning from the patient himself, allogenic, meaning from a human donor not immunologically identical, or xenogenic, meaning from a different species (Naughton, 2002) . Autologous cells represent an excellent source for use in TE because of the low risk of immune complications. However, they are not cost-effective or batch controlled for universal clinical use (Knight and Evans, 2004) . In addition, for many patients with extensive end-stage organ failure, a tissue biopsy may not yield enough healthy cells for expansion and transplantation. In contrast, the use of allogenic cells for TE offers advantages over autologous cells in terms of the uniformity, the standardization of procedure, the quality control and the cost-effectiveness (Knight and Evans, 2004). Use of amniotic membrane for tissue engineering
Human embryonic stem cells as a source of stem cells for TE
Human embryonic stem cells (HESCs) are an interesting example of allogenic cells that are currently used for TE. HESC lines are derived from the inner cell mass of 3-5-day-old blastocysts as originally described by Thomson et al. (1998) . HESCs possess high levels of telomerase activity and express the surface markers, SSEA-4, TRA (tumour rejection antigen)-1-60 and TRA-1-81 (Reubinoff et al., 2000) . In addition, they also show high expression of octamer binding protein 4 (Oct-4) and Nanog (Reubinoff et al., 2000; Chambers et al., 2003) . Using these HESCs, researchers have been successful in generating cells of ectodermal, endodermal, and mesodermal lineage. This differentiation was determined using the formation of embryoid bodies in vitro and teratomas in vivo (Thomson et al., 1998) . Teratomas form when embryonic stem cells are injected into severe combined immunodeficient (SCID) mice and tissue types formed include gut epithelium, cartilage, bone and neural epithelium among others (Thomson et al., 1998) . In spite of all advantages of embryonic stem cells, they have major limitations for use in TE.
A fundamental bottleneck that must be overcome in order to use stem cells for TE is the limited supply of stem cells (Chai and Leong, 2007) . This problem becomes more critical as the engineering of bulk tissues or complex organs is contemplated. Such goals would necessitate the maintenance of large quantities of undifferentiated cells to provide sufficient starting material. With a limited supply of embryonic stem cells, extensive in vitro expansion would be required to obtain a sufficient number of cells for therapeutic purposes. At first, it was assumed that the in vitro expansion conditions for HESC lines were very similar to those used for mouse embryonic stem cells line. However, it was soon discovered that, although mouse embryonic stem cells could proliferate and remain undifferentiated in the absence of fibroblast feeder layer and in the presence of leukemia inhibitory factor (LIF), the same is not true for HESCs (Thomson et al., 1998) . LIF maintains mouse embryonic stem cells by activating the STAT3/gp130 pathway. Though treatment of HESCs with exogenous LIF activates the same pathway, this is insufficient to maintain the self-renewal of these cells (Daheron et al., 2004) . Thus, HESCs have been mostly derived and cultured on a layer of mouse embryonic fibroblasts (MEFs). The concern over xenogenic contaminants from the mouse feeder cells may be a limiting factor for transplantation to humans (Mallon et al., 2006) . For example, it has been reported that HESCs cultured with MEF might take up and express Neu5Gc, a nonhuman sialic acid, capable of inducing an immune response in humans (Martin et al., 2005) . In addition to immune restrictions concerning transplantation studies, the mouse feeder layer may be also an unexpected source of variability when trying to control experimental conditions (Heng et al., 2004) . Another potential problem of using HESC for transplantation is tumourgenicity. Undifferentiated cells that retain pluripotency give rise to tumours known as teratomas in vivo (Mitjavila-Garcia et al., 2005) . In addition, the difficulties in obtaining HESCs as well as important ethical concerns make the use of HESCs an improbable candidate for TE (Bobbert, 2006; Lei et al., 2007) .
Amniotic epithelium as a source of stem cells for TE
Amniotic epithelial cells (AECs) have several characteristics that make them a great source of stem cells for TE. Similar to the three germ layers of the embryo, including the ectoderm, mesoderm, and endoderm; the amniotic epithelium derives itself from the epiblast prior to gastrulation (Parolini and Soncini, 2006) . This would suggest that the amniotic epithelium might retain a reservoir of stem cells all throughout pregnancy. Recent studies aimed at defining the stem cell-like characteristics of AECs have determined that these cells express the surface markers associated with embryonic stem cell, e.g. SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81. These cells also express pluripotent stem cell-specific transcription factors such as Oct-4 and Nanog (Miki et al., 2005; Miki et al., 2007a) . The pluripotency of amniotic cells has been confirmed by formation of a xenogenic chimera from AECs and mouse embryonic stem cells in vitro. This chimera gives rise to cells of all germ layers (Tamagawa et al., 2004) . Additional experiments have demonstrated in vitro differentiation of AECs into the three germ layers for cardiac cells (mesodermal lineage), neuronal and glial cells (ectodermal lineage), and pancreatic and hepatic differentiation (endodermal lineage). All of these cells show positivity for specific markers (Miki et al., 2005; Ilancheran et al., 2007) . For example, cultivated human AECs demonstrate albumin production, glycogen storage and albumin secretion consistent with alpha1-antitrypsin and other hepatocyte gene expression profiles (Takashima et al., 2004) .
Clonogenicity is the ability of a single cell to form a cloned colony and is a key defining function that demonstrates the self-renewal properties of stem cells. AECs are clonogenic and their cloning efficiency is comparable to some HESC lines (Ilancheran et al., 2007) . As described previously, teratoma formation is an important limiting factor ascribed to pluripotent HESCs in TE use. While it has been shown that AECs are pluripotent, these cells do not form teratomas when transplanted into the testes of SCID mice (Ilancheran et al., 2007; Miyamoto et al., 2004) . This is supported by studies using AECs to repair damaged ocular surfaces (Tseng et al., 1998; Ucakhan et al., 2002; Solomon et al., 2002) or amnion cells to improve congenital lysosomal storage disease (Kosuga et al., 2000) . It is possible that the lack of telomerase activity in AECs may contribute to tumour suppression in vivo (Miki et al., 2005; Mosquera et al., 1999) . It has also been shown that native AECs express the non-polymorphic, non-classical human leukocyte antigen (HLA-G) (Lefebvre et al., 2000) , but lack the polymorphic antigens HLA-A, -B (Class IA) and HLA-DR (Class II) on their surfaces (Sakuragawa et al., 1995) . These finding suggest that AECs maybe Use of amniotic membrane for tissue engineering immunologically inert and would have reduced risk of rejection or immune reaction upon transplantation. Another important advantage of AECs over HESCs is related to their method of culturing. These cells can proliferate without needing a second cell type serving as a feeder layer. AECs create their own feeder layer with some cells spreading out at the bottom of the culture dish. This basal layer of AECs that attaches to the culture dish may play the role of an autologous feeder layer, serving as a substrate for attachment or possibly providing secreted factors that help induce or maintain undifferentiated AECs (Miki et al., 2005) . The other advantage of AECs is large numbers of these cells. It has been reported that an average yield is more than 100 million AECs per amnion collected (Miki et al., 2005) . With attention to the robust proliferation of these cells in the presence of certain growth factors such as EGF, large numbers of stem cells could potentially be available using the amniotic membrane as a source (Terada et al., 2000) . In addition, discarding of the amniotic membrane after human Caesarean sections allows scientists to avoid the ethical concerns associated with collecting HESCs.
To isolate AECs, the AM is separated from the underlying chorion by mechanical peeling. After several washes with a buffered saline solution containing antibiotics, the AM is digested using enzymes, such as trypsin, dispase II and a combination of trypsin and EDTA. After digestion, AECs are isolated with centrifugation. It has been reported that separation of AECs using a density gradient is a practical method to select for SSEA-4 positive AECs (Miki et al., 2007b) .
The amniotic membrane as a scaffold for TE
A major prerequisite for choosing a scaffold is its biocompatibility. Biocompatibility is the property of being biologically compatible as a result of not producing a toxic, injurious, carcinogenic, or immunological response in living tissue (Baguneid et al., 2006) . Scaffolds must not be destroyed by inflammation yet should be able to react to an appropriate host response (Young et al., 2005) . In addition, their mechanical properties should include permeability, stability, elasticity, flexibility, plasticity, and resorbability at a rate congruent with tissue replacement (Yang et al., 2001) . Scaffolds should also allow cell adhesion and the potential for delivery of biomodulatory agents such as growth factors and genetic materials (Walgenbach et al., 2001) .
The attachment of a cell to a scaffold is largely affected by the components of the scaffold's extracellular matrix (ECM). The presence or absence of certain ECM molecules such as collagen, laminin, fibronectin and vitronectin within any basement membrane has a huge influence on the adhesion and growth of the overlying stem cells. As well as allowing the cells to attach and migrate, the ECM molecules also serve as adhesion ligands, which transmit signals via their interaction at cell surface receptors. Cells detect and respond to numerous features of the ECM, including the composition and availability of the adhesive ligands, the mechanical stiffness of the matrix and the spatial and topological organization of the scaffolds, through surface receptors known as integrins (Sniadecki et al., 2006) . Integrins are transmembrane receptors that have an extracellular domain, which bind to the ECM, and an intracellular domain that links to the cytoskeleton. After ligand binding, the integrin receptors are recruited into distinct dot-like or streak-like nano-or microdomains on the cell membrane, called "focal adhesions" (Bacakova et al., 2004) . In these regions, the integrins communicate with many specific structural and signalling molecules. Some proteins such as talin, filamin, paxillin or vinculin, act as linkers between the integrin receptors and the cytoplasmic actin of the cytoskeleton. In turn, the cytoskeleton is associated with the nuclear membrane, membranes of cellular organelles as well as with various enzymes. Thus, integrins influence intracellular processes important for cell transport, including endocytosis and exocytosis, as well as the processes of cell proliferation, differentiation or apoptosis (Moiseeva, 2001; Aplin, 2003) . The dual nature of adhesion molecules, i.e. their mechanical and signaling activity, indicate that they act as sensors of the ECM environment (sensing both mechanical and biochemical changes in the ECM), regulators of the cytoskeleton, and centres of signal transduction (Burridge and Chrzanowska-Wodnicka, 1996; Geiger et al., 2001) . Therefore, a scaffold with the preferred ECM components would be a preferred matrix for TE.
The AM is a scaffold with a template of the ECM. AECs secrete collagen type III and IV and noncollagenous glycoproteins (laminins, nidogen, and fibronectin) that form the basement membrane of the AM (Fig. 1) . The spongy layer on the stromal portion of the amnion has an abundance of hydrated proteoglycans and glycoproteins and contains a nonfibrillar network of mostly type III collagen (Parry and Straus, 1998) . Perlecan, a large (467 kDa) heparan sulphate proteoglycan is an important component of the basement membrane. Perlecan is involved in the binding of growth factors and interacts with various extracellular proteins and cell adhesion molecules (Murdoch et al., 1992) .
The AM can be used either with amniotic epithelium (intact AM) or without it (denuded AM). To remove the amniotic epithelium, the AM is incubated in EDTA at 37°C and the cells are gently scraped with a cell scraper under a microscope. Although complete removal of cellular components from AM is important for the denudation protocol, the structural components of the remaining scaffold must be retained. It has been determined that a detergent-based protocol with sodium dodecyl sulphate (SDS) can remove amniotic epithelium from AM while maintaining the histoarchitecture of the matrix (Wilshaw et al., 2006) .
While the use of fresh AM for transplantation in humans has been described, special processing and sterilization is recommended to ensure consistent quality and preservation of the AM. Various methods have been used to preserve the AM including hypothermic storage (at 4°C), freeze drying, γ-sterilization, glycerolpreservation and cryopreservation. The influences of these different preservation methods on the viability of cells and Use of amniotic membrane for tissue engineering growth factors of the AM are yet to be determined. It has been determined that storage of the AM in glycerol at 4°C results in immediate cell death (Hennerbichler et al., 2007a) . Cryopreservation with dimethylsulphoxide (DMSO) at -80°C allows retention cells in the AM at approximately 50% for several months (Kubo et al., 2001) . It has also been reported, though, that several angiogenic growth factors and cytokines are removed during crypreservation of the AM (Hennerbichler et al., 2007b) . However, if the AM is cryopreserved in 50% glycerol, the viability of AECs is lost (Kruse et al., 2000) . In general, cell viability of the AM depends on the media composition and storage temperature of the preservation process. Sterilization with γ-rays has no significant effect on growth factor content in the human AM while removal of epithelium eliminates nearly all important growth factors (Branski et al., 2007) . It has been shown that native, intact AM contains higher levels of EGF, KGF, HGF and bFGF compared to epithelially denuded AM (Koizumi et al., 2000) , suggesting that these growth factors are predominantly present in the amniotic epithelium. In addition, TNF-α, NGF, BDNF, noggin and activin has been also detected in AECs (Uchida et al., 2000; Koyano et al., 2002) . Therefore the amniotic epithelium contains cytokines that play a crucial role in the microenvironmental niche of some progenitor cells. It was demonstrated that the resultant expanded epithelium on intact amniotic membrane indeed adopts a limbal epithelial phenotype whereas that on denuded amniotic membrane revealed a corneal epithelial phenotype (Grueterich et al., 2003) . However, presence of an amniotic epithelium may hinder the uniform expansion of explants cultured on the membrane and delay the formation of strong hemidesmosomal attachment (Burman et al., 2004) . Therefore, determining which AM preparation, intact or denude, is appropriate for TE depends on other conditions, including the type of cells or tissue is being used. Further studies are needed to elucidate the potential mechanisms of action.
The human AM is now widely used to reconstruct the ocular surface for the treatment of several conditions, including intractable epithelial defects, chemical burns, partial limbal cell deficiencies, ocular cicatricial pemphigoid, and Stevens-Johnson syndrome (Tseng et al., 1998; Azuara-Blanco et al., 1999; Tsubota et al., 1996; Chen et al., 2000) . Several experimental studies have been performed using the AM as a scaffold. It has been reported that the ECM of the human amnion is an effective conduit for peripheral nerve regeneration and that the AM is a biodegradable scaffold with unique biochemical and mechanical characteristic for nerve regeneration (Mohammad et al., 2000; Mligiliche et al., 2002) . It has also been demonstrated that denuded AM can be utilized as a feeder layer for some stem cells and may be used for neuronal differentiation (Miyamoto et al., 2004; Ueno et al., 2006; Meng et al., 2007) . Denuded AM has been investigated as a carrier of chondrocytes, and it has been suggested that the AM can serve as a carrier matrix for cartilage regeneration (Jin et al., 2007) . When epithelial and mesenchymal cells are seeded on a cellular scaffold created from the AM, the cells were highly interconnected and capable of penetrating the porous structure of the amnion scaffold. These experiments suggest a promising new approach for the repair of a prematurely ruptured foetal membrane (Portmann-Lanz et al., 2007) . Cultivation and seeding of epithelial cells on an amnion scaffold is a frequently used method for ocular surface and skin reconstruction (Fatima et al., 2006; Yang et al., 2006; Capeans et al., 2003) . And lastly, cultivation of endothelial cells on an AM scaffold has also been reported as a potential approach for vascular TE (Ishino et al., 2004; Tsai et al., 2007) . A summary of potential applications of AM scaffolds for different tissues is summarized in The AM can be used either with amniotic epithelium (intact) or without it (denuded), preserved or alone. In some studies, prior to preservation, the cells have been removed from the AM. AM: amniotic membrane, AECs: amniotic epithelial cells.
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Other properties of the amniotic membrane Anti-inflammatory and anti-microbial Tissue engineered constructs often provoke an inflammatory reaction known as a foreign body reaction upon implantation. These implanted materials can be degradable or non-degradable. While inflammation can be good in some instances to trigger the healing of an injury, it can also lead to implant failure. Foreign body reactions evoke stimulation of giant cells and macrophages that produce cytokines and attract fibroblasts, leading to fibrosis. These fibroblasts are activated by the transforming growth factor (TGF)β (Khouw et al., 1999) . The AM down-regulates TGF-β and its receptor expression by fibroblasts and in doing so, reduce the risk of fibrosis. Therefore, an AM scaffold can modulate the healing of a wound by promoting tissue reconstruction rather than promoting scar tissue formation (Tseng et al., 1999; Lee et al., 2000) .
There are several reports of the AM reducing inflammation. The AM stromal matrix markedly suppresses the expression of the potent pro-inflammatory cytokines, IL-1α and IL-1β (Solomon et al., 2001) . Matrix metalloproteases (MMPs) are expressed by infiltrating polymorphonuclear cells and macrophages. Natural inhibitors of MMPs have been found in the AM (Hao et al., 2000; Kim et al., 2000) . Hyaluronic acid is a highmolecular-weight glycosaminoglycan that exists in large quantities in the AM and acts as a ligand for CD44, which is expressed on inflammatory cells and plays an important role in adhesion of inflammatory cells, including lymphocytes, to the AM stroma (Higa et al., 2005) .
The β-defensins are a major group of anti-microbial peptides that are expressed at mucosal surfaces by epithelial cells and leukocytes, and are an integral part of the innate immune system (Krisanaprakornkit et al., 1998; Harder et al., 2000) . The innate immune system has evolved to eliminate microorganisms upon entry into the tissues, creating antigens necessary to produce an adaptive immune response. ACEs also have the ability to produce β-defensins (King et al., 2007) . The β3-defensin is the predominant defensin in the amniotic epithelial (Buhimschi et al., 2004) . In addition, 2 low-molecular-mass elastase inhibitors, secretory leukocyte proteinase inhibitor (SLPI) and elafin, are expressed in the AM (King et al., 2007; Buhimschi et al., 2004) . In addition to their antiinflammatory properties, elafin and SLPI both have antimicrobial actions and act as components of the innate immune system to protect related surfaces from infection (King et al., 2003) . Treatment of the AM with both lactoferrin and interleukin-1 receptor antagonists make the AM both anti-microbial and anti-inflammatory (Kanyshkova et al., 2001) . Lactoferrin is a globular multifunctional protein, which has both anti-microbial and antiinflammatory effects, by serving as an antioxidant and an iron chelator in tissues (Gomes et al., 2005) . Lactoferrin suppresses the production of interleukin-6 in the amniotic fluid during amniotic infection (Kanyshkova et al., 2001) . By contrast, the interleukin-1 receptor antagonist is a potent inhibitor of interleukin-1 and thus will suppress the inflammation mediated by interleukin-1 (Romero et al., 1994) .
Low immunogenicity
Low risk of immunogenicity is an important component of creating a biocompatible scaffold for TE. Considering most ECM components in the creation of scaffolds are of xenogenic origin, (e.g. bovine type I collagen is harvested from Achilles tendon is perhaps the most commonly used xenogenic ECM component intended for therapeutic applications) it is important to consider the immunogenicity of the scaffold. Some experimental changes made to native biomaterials can result in an increased immune response upon transplantation. For example, methods of chemically cross-linking the ECM for purposes of increased material strength and slower in vivo degradation have uniformly resulted in a scaffold material that is less biocompatible than ECM that is preserved in its native state (Badylak, 2004) .
In another example, the extraction of specific ECM components for therapeutic use involves the decellularization of mammalian tissue. An ECM scaffold alone (without the accompanying cells) and the potential degradation products might act as potential antigenic or inflammatory stimuli in vivo. Hence, the immunologic responses to the ECM alone are distinctly different than those observed when cells are embedded within the ECM and cell death and cell debris are components of the host response. In spite of the extensive measures taken to decellularize tissues in the preparation of ECM scaffolds, the complete elimination of all cell membrane and nuclear materials is very difficult and perhaps impossible. Hence, investigation into the immunogenicity of cellular components will also be important. For example, one of the major barriers to xenotransplantation in humans is the presence of natural antibodies to the terminal galactose alpha 1, 3 galactose (alpha-gal) epitope. This epitope is expressed on all mammalian cell membranes except those of human and old world primates. In humans, these naturally occurring antibodies can be of the IgM, IgG or IgA isotype and often mediate hyper-acute or delayed rejection of implants (Sandrin et al., 1993; Schussler et al., 2001) .
Use of the AM as a scaffold for tissue engineering will bypass the immunological complications of xenogenic biomaterials. Studying immune responses during pregnancy will be an important first step for the investigation of AM immunogenicity. One masterpiece of creation manifests itself in pregnancy. Considering that half of the zygote is composed of the father's DNA, the foetus has semi-allogenic antigens recognized by the mother. However, the pregnancy is established normally in most cases, without rejection. There may be several mechanisms involved with protecting the foetus from a maternal immune response. Both local and systemic nonspecific suppressor mechanisms have been described which may down-regulate maternal immune responses without significantly impairing the ability to fight infections. The placental barrier restricts the traffic of cytotoxic cells to the foetus, and therefore, cytotoxic antibodies are removed by the placental before they reach the foetal circulation. The major factor, which appears to prevent the rejection of the trophoblast, is its expression of HLA-G. In contrast to HLA-A and -B class I genes, Use of amniotic membrane for tissue engineering which are down regulated in human trophoblast cells, nonpolymorphic class I molecules including HLA-G are expressed in extra-villous cytotrophoblast and also in amnion cells and amniotic fluid. The role of the highly polymorphic classical class I molecules HLA-A, -B, -C, is to induce a specific immune response by presenting peptide antigens to T cells. In contrast, the HLA-G is thought to be involved in the induction of immune tolerance by acting as ligand for inhibitory receptors present on NK cells and macrophages (Sargent, 1993; Szekeres-Bartho, 2002) .
As the AM is originally foetal tissue, all information described above holds true. As previously mentioned, AECs do not express HLA-A, -B, -D, and -DR antigens on the cell surface, but express HLA-G on their surfaces, suggesting that acute rejection would not occur after transplantation (Hori et al., 2006) . It has been also reported that HLA-G gene is up-regulated in conjunctival and limbal epithelial cells when these cells are cultured on denuded AM (Higa et al., 2006) . Although the immunogenicity of the AM is controversial, in general, it is believed that the AM possesses low immunogenicity (Hori et al., 2006) . In addition, it is generally thought that the immunogenicity of cryopreserved AM tissue is less than that of fresh AM tissues and that cryopreserved cells are expected to be nonviable. This approach guides some researches to use of cryopreserved AM instead of fresh AM (Kubo et al., 2001) .
Mechanical properties
Often a graft site must bear loads at or close to physiological levels very soon after transplantation. Internal fixation often provides the necessary early stability. However, in some tissues, the scaffold must bear or share substantial load early after transplantation. In addition, because mechanical signals are important mediators of differentiation for some progenitor cells, the scaffold must create an appropriate environment throughout the site where new tissue is desired. Increased stiffness enhances scaffold strength necessary to resist stress induced during the growth of tissue (Kim et al., 1999; Sikavitsas et al., 2001) . The elasticity, stiffness and other biomechanical properties of the ECM depend on the variation in its ingredients, such as collagen, proteoglycan and elastin (Kiviranta et al., 2006) .
Most research performed, up to now, on the biomechanical properties of the AM has been for the investigation of premature rupture of the foetal membrane (PROM). PROM is defined as rupture of chorioamnion prior to the onset of labour. The foetal membrane must bear the load of hydrostatic pressure from amniotic fluid during gestation. In addition to chronic load of during normal pregnancy, foetal membranes must also likely bear repetitive minor loads, such as Braxton-hicks contractions (Bittar et al., 1996) . The AM is approximately 20% of the chorioamnion thickness at term, but dominates the mechanical responses of the bi-layer, with both stiffness and strength by an order of magnitude greater than the chorion layer. Hence, the strength of the intact chorioamniotic membrane is primarily determined by the AM (Oxlund et al., 1990) . Because of mechanical importance in vivo, the foetal membrane, and particularly the amnion layer, has been the focus of a number of in vitro mechanical studies. With these mechanical studies, the baseline mechanical properties of a soft tissue membrane can be assessed. The baseline properties in isolation are of interest primarily for in vitro mechanical modelling purposes and for matching in the case of TE replacement (Oyen et al., 2005; Calvin and Oyen, 2007) .
The AM demonstrates a mechanical response that is inherently time-dependent, described as "viscoelastic". (Lavery and Miller, 1997; Oyen et al., 2005; Calvin and Oyen, 2007) . Viscoelasticity is a critical property of scaffolding in a majority of tissues. For example, very stiff scaffolds lack the viscoelastcity of arteries, promoting intimal hyperplasia and occlusion (Sarkar et al., 2007) . Although, it has been shown that preterm AM has a greater mechanical integrity than term AM, the stiffness of term AM is more reasonable for a majority of tissue engineering protocols (Mohammad et al., 2000; Jin et al., 2007; He et al., 2002; Wilshaw et al., 2006) . One measure of elasticity is the Young's modulus, which is normally applied in mechanical physics and is defined as the ratio of applied stress to strain. It reported that Young's modulus of preterm (26-36 weeks) human AM is 3.6 MPa, whereas this modulus for term (36-40 weeks) human AM is 2.29 MPa (Benson-Martin et al., 2006) . This mechanical change may be related to the collagen content, although there are conflicting reports regarding whether the amnion collagen content actually decreases with gestational age (BensonMartin et al., 2006; Manabe et al., 1991) . It is also worth noting that elastin, which is detected in the foetal amnion, is proposed to provide the molecular basis for elasticity in the AM (Hieber et al., 1997) .
Amniotic membrane: hype or hope
Despite all of the advantages of AM for TE, some pitfalls must be overcome before the AM is used therapeutically for TE. The AM is a biological-derived material and concomitant are the same problems of other biological material applications. For instance, transmission of infectious diseases is always a risk associated with human organ and tissue transplantation. Thus, the same precautions and safety criteria applied to organ transplantation have to be adhered in the application of AM. Potential donors need to be screened effectively for any risk factors that might render them unsuitable for donation. A review of relevant medical records to ensure freedom from risk factors for and clinical evidence of HIV, hepatitis B, hepatitis C, CMV, syphilis, and other possible infections, should be carried out. There is a slight possibility that the donor may be in the "window period" of infection. Hence, even if serological tests are negative, it is advisable to repeat the investigations after 6 months. The AM can be preserved at -80°C until samples found negative of any infectious diseases (Fernandes et al., 2005) .
A placenta obtained shortly after elective Caesarean delivery is the preferred source of an AM. Placentas from vaginal deliveries or subsequent to PROM are known to be contaminated and therefore unsuitable for transplantation. Use of amniotic membrane for tissue engineering
The comprehensive mapping of foetal membranes at term, detected an area of the membrane that exhibited unique morphological features, which were only found within a restricted area, termed as "zone of altered morphology" (ZAM). This feature includes structural weaknesses and a marked disruption of the connective tissue layers as well as a marked reduction of the thickness and cellularity of the membrane (Malak and Bell, 1994) . Apoptosis of cells and degradation of basement membrane by MMPs in ZAM are the proposed mechanism for these features (Moore et al., 2006) . Due to decreased integrity and increased apoptosis of cells in this region, use of the ZAM is not preferred.
As mentioned, AECs have many characteristics similar to stem cells, but one of the most important properties of stem cells is that they survive freeze-thaw. In contrast, it has been shown that the viability of AECs decrease after freezing (Kubo et al., 2001) . Hence, if a stable and longterm supply of AECs is realized, it could be applied to the transplantation therapy for a wide variety of diseases.
There are other problems that might arise with the use of the AM for tissue engineering. The AM is a thin structure and has its technical limitations with regards to suturing. A new approach might include the use of glues as a substitute for suturing (Szurman et al., 2006) .
In the past decade, the AM has been greatly used in the field of ophthalmology. Therefore, much of what we know is derived from its uses in this field. A comparison of its ophthalmologic uses with its potential uses with other tissues that have different characteristics (e.g., different mechanical properties) will be necessary.
Despite the few obstacles mentioned above, the future of the AM in applications such as TE is very exciting. However, further work is needed to determine the full potential of the AM for the uses described in this review.
Conclusions
The AM has many characteristics, which make it potentially suitable for use in TE. The epithelial layer of the AM includes cells that have similar characteristics to stem cells. As described, these cells express pluripotent markers of stem cells and can be differentiated into all three germ layers. AECs are not, however, tumourigenic upon transplantation. These cells have no need for a feeder layer throughout their cultivation. In addition, there are many other advantages that suggest AECs are an excellent source of cells for TE.
The AM can act as a scaffold for TE. The ECM components of the basement membrane from the AM include collagen, fibronectin, laminin and other proteoglycans important for overlying cell growth. These ingredients are the ligands for integrin receptors, and hence, have a great role in cell adhesion during the cell seeding protocol. Other properties of the AM include antiinflammation, anti-fibrosis, anti-scaring, anti-microbial, low immunogenicity and reasonable mechanical property, which are all important for use in TE.
However, the AM, like other biological material, has some problems described above and its uses should be carefully carried out. Meanwhile, the manifestation of its many different uses in other future studies will facilitate in its application in TE.
